The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.
Ubrelvy and Nurtec are prescription medications taken to treat migraines. Though they share similarities, Ubrelvy is for acute treatment, while Nurtec can be taken for immediate symptom relief.
Mind+ Neurology is advancing medical research and offering hope to patients living with migraine. Aaron Hart & Kelly Reynolds ...
The US Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.
1:44 FDA approves 1st new type of pain medication in decades U.S. officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with ...